ETI During Spinal Trauma

NCT ID: NCT02295631

Last Updated: 2014-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to compare time, success rates of different tracheal tubes (standard tube and ETView VivaSight SL) for intubation with an immobilized cervical spine in a standardized manikin model.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intubation Cardiac Arrest

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ETI during immobilized spine (oral intubation)

intubation with immobilized cervical spine endotracheal intubation with immobilized cervical spine

Group Type EXPERIMENTAL

Standard tracheal tube

Intervention Type DEVICE

ETI with standard tracheal tube and Macintosh laryngoscope

ETView VivaSight SL

Intervention Type DEVICE

ETI with ETView VivaSight SL

ETI during immobilized spine (nasal intubation)

intubation with immobilized cervical spine endotracheal intubation with immobilized cervical spine

Group Type EXPERIMENTAL

Standard tracheal tube

Intervention Type DEVICE

ETI with standard tracheal tube and Macintosh laryngoscope

ETView VivaSight SL

Intervention Type DEVICE

ETI with ETView VivaSight SL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard tracheal tube

ETI with standard tracheal tube and Macintosh laryngoscope

Intervention Type DEVICE

ETView VivaSight SL

ETI with ETView VivaSight SL

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* give voluntary consent to participate in the study
* minimum 1 year of work experience in emergency medicine
* experienced emergency medicine personnel (physicians, nurses, paramedics)

Exclusion Criteria

* not meet the above criteria
* wrist or low back diseases
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

International Institute of Rescue Research and Education

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lukasz Szarpak

Lukasz Szarpak

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

International Institute of Rescue Research and Education

Warsaw, Masovia, Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Andrzej Kurowski

Role: CONTACT

+48500186225

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lukasz Szarpak

Role: primary

+48500186225

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ETI/2014/42

Identifier Type: -

Identifier Source: org_study_id